NYSE: CI | Healthcare / Healthcare Plans / USA |
285.08 | +0.6700 | +0.24% | Vol 959.69K | 1Y Perf -2.94% |
Oct 4th, 2023 16:00 DELAYED |
BID | 281.15 | ASK | 287.79 | ||
Open | 284.35 | Previous Close | 284.41 | ||
Pre-Market | - | After-Market | 285.08 | ||
- - | - -% |
Target Price | 344.00 | Analyst Rating | Moderate Buy 1.97 | |
Potential % | 20.67 | Finscreener Ranking | ★★★ 48.71 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-89 | Value Ranking | ★★★ 51.21 | |
Insiders Value % 3/6/12 mo. | -100/-100/-99 | Growth Ranking | ★★★+ 55.61 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-99 | Income Ranking | ★★★ 46.41 | |
Price Range Ratio 52W % | 44.75 | Earnings Rating | Sell | |
Market Cap | 84.38B | Earnings Date | 2nd Nov 2023 | |
Alpha | 0.00 | Standard Deviation | 0.08 | |
Beta | 0.64 |
Today's Price Range 281.70285.56 | 52W Range 240.50340.11 | 5 Year PE Ratio Range 8.3029.50 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Neutral |
Performance | |||
---|---|---|---|
1 Week | -1.46% | ||
1 Month | 2.80% | ||
3 Months | 1.46% | ||
6 Months | 10.86% | ||
1 Year | -2.94% | ||
3 Years | 70.07% | ||
5 Years | 33.76% | ||
10 Years | 259.27% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 10.47 | |||
ROE last 12 Months | 15.53 | |||
ROA (5Y Avg) | 2.48 | |||
ROA last 12 Months | 4.81 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | - | |||
Return on invested Capital Q | - | |||
Return on invested Capital Y | - | |||
Assets Turnover | 1.00 | |||
Receivables Turnover | - |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
14.40 | ||||
2.05 | ||||
0.69 | ||||
8.90 | ||||
9.90 | ||||
33.94 | ||||
-2.75 | ||||
147.32 | ||||
117.04B | ||||
Forward PE | 10.13 | |||
PEG | 1.29 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
0.38 | ||||
0.70 | ||||
8.00 | ||||
Leverage Ratio | 3.30 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
5.30 | ||||
- | ||||
6.00 | ||||
4.13 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
134.27B | ||||
439.17 | ||||
22.91 | ||||
40.78 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.48 | ||||
4.48 | ||||
328.24 | ||||
113.51 | ||||
Payout ratio | 4.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2023 | 5.98 | 6.13 | 2.51 |
Q01 2023 | 5.23 | 5.41 | 3.44 |
Q04 2022 | 4.84 | 4.96 | 2.48 |
Q03 2022 | 5.70 | 6.04 | 5.96 |
Q02 2022 | 5.44 | 6.22 | 14.34 |
Q01 2022 | 5.13 | 6.01 | 17.15 |
Q04 2021 | 4.68 | 4.77 | 1.92 |
Q03 2021 | 5.23 | 5.73 | 9.56 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
9/2023 QR | 6.66 | -4.03 | Negative |
12/2023 QR | 6.61 | 2.64 | Positive |
12/2023 FY | 24.80 | -0.08 | Negative |
12/2024 FY | 28.23 | -0.18 | Negative |
Next Report Date | 2nd Nov 2023 |
Estimated EPS Next Report | 6.66 |
Estimates Count | 10 |
EPS Growth Next 5 Years % | 11.20 |
Volume Overview | |
---|---|
Volume | 959.69K |
Shares Outstanding | 295.98K |
Shares Float | 294.69M |
Trades Count | 22.93K |
Dollar Volume | 272.66M |
Avg. Volume | 1.13M |
Avg. Weekly Volume | 1.08M |
Avg. Monthly Volume | 1.04M |
Avg. Quarterly Volume | 1.27M |
Cigna Corporation (NYSE: CI) stock closed at 284.41 per share at the end of the most recent trading day (a -1.09% change compared to the prior day closing price) with a volume of 971.76K shares and market capitalization of 84.38B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 73700 people. Cigna Corporation CEO is David M. Cordani.
The one-year performance of Cigna Corporation stock is -2.94%, while year-to-date (YTD) performance is -14.16%. CI stock has a five-year performance of 33.76%. Its 52-week range is between 240.5 and 340.11, which gives CI stock a 52-week price range ratio of 44.75%
Cigna Corporation currently has a PE ratio of 14.40, a price-to-book (PB) ratio of 2.05, a price-to-sale (PS) ratio of 0.69, a price to cashflow ratio of 8.90, a PEG ratio of 1.29, a ROA of 4.81%, a ROC of -% and a ROE of 15.53%. The company’s profit margin is 4.13%, its EBITDA margin is -%, and its revenue ttm is $134.27 Billion , which makes it $439.17 revenue per share.
Of the last four earnings reports from Cigna Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $6.66 for the next earnings report. Cigna Corporation’s next earnings report date is 02nd Nov 2023.
The consensus rating of Wall Street analysts for Cigna Corporation is Moderate Buy (1.97), with a target price of $344, which is +20.67% compared to the current price. The earnings rating for Cigna Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cigna Corporation has a dividend yield of 1.48% with a dividend per share of $4.48 and a payout ratio of 4.00%.
Cigna Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 12.99, ATR14 : 5.09, CCI20 : -21.27, Chaikin Money Flow : -0.08, MACD : 1.20, Money Flow Index : 45.91, ROC : 0.42, RSI : 47.90, STOCH (14,3) : 20.72, STOCH RSI : 0.00, UO : 43.67, Williams %R : -79.28), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cigna Corporation in the last 12-months were: Cordani David (Sold 20 148 shares of value $5 924 721 ), Cynthia Ryan (Option Excercise at a value of $521 936), Cynthia Ryan (Sold 3 812 shares of value $1 222 932 ), David M. Cordani (Sold 20 148 shares of value $5 924 721 ), Donna F. Zarcone (Sold 2 088 shares of value $567 247 ), Elder Granger (Sold 322 shares of value $87 478 ), Eric Palmer (Sold 4 000 shares of value $1 200 004 ), Everett Neville (Sold 5 208 shares of value $1 462 400 ), Granger Elder (Sold 322 shares of value $87 478 ), Jason D. Sadler (Option Excercise at a value of $8 107 870), Jason D. Sadler (Sold 33 334 shares of value $11 129 526 ), Jones Nicole (Sold 6 067 shares of value $1 780 707 ), Michael Triplett (Sold 1 731 shares of value $470 261 ), Neville Everett (Option Exercise at a value of $3 024 778), Neville Everett (Sold 18 365 shares of value $5 346 478 ), Nicole S. Jones (Sold 5 404 shares of value $1 589 100 ), Paul A. Sanford (Sold 373 shares of value $111 900 ), Ryan Cynthia (Option Excercise at a value of $513 936), Ryan Cynthia (Sold 4 571 shares of value $1 299 535 ), Sanford Paul A (Sold 1 507 shares of value $444 881 ), Triplett Michael (Sold 1 731 shares of value $470 261 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Moderate Buy |
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
CEO: David M. Cordani
Telephone: +1 860 226-6000
Address: 900 Cottage Grove Road, Bloomfield 06002, CT, US
Number of employees: 73 700
Wed, 09 Aug 2023 09:01 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Cigna (CI), Keros Therapeutics (KROS) and Qiagen (QGEN)
- TipRanks. All rights reserved.Tue, 08 Aug 2023 09:20 GMT Analysts Offer Insights on Healthcare Companies: Inogen (INGN), Cigna (CI) and Stryker (SYK)
- TipRanks. All rights reserved.Mon, 07 Aug 2023 02:30 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Cigna (CI) and Ultragenyx Pharmaceutical (RARE)
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.